Search Results - Felker, G.M

  • Showing 1 - 7 results of 7
Refine Results
  1. 1
    Prevalence of AAV1 neutralizing antibodies and consequences for a clinical trial of gene transfer for advanced heart failure

    Prevalence of AAV1 neutralizing antibodies and consequences for a clinical trial of gene transfer for advanced heart failure by Greenberg, B, Butler, J, Felker, G M, Ponikowski, P, Voors, A A, Pogoda, J M, Provost, R, Guerrero, J, Hajjar, R J, Zsebo, K M

    Published in Gene therapy
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Association between VE-VCO2 Slope and Resting Hemodynamic Measurements in Ambulatory Heart Failure (HF) Patients: An Analysis from the Duke Advanced HF Database

    Association between VE-VCO2 Slope and Resting Hemodynamic Measurements in Ambulatory Heart Failure (HF) Patients: An Analysis from the Duke Advanced HF Database by Patel, C, Mentz, R.J, Suarez, J, Hernandez, A.F, Felker, G.M, O'Connor, C.M, Rogers, J.G

    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Rationale and Design for a Phase II Study Evaluating the Effect of the Cardiac Myosin Activator, CK-1827452, on Cardiac Function, Hemodynamics, and Myocardial Oxygen Consumption in Patients with Heart Failure

    Rationale and Design for a Phase II Study Evaluating the Effect of the Cardiac Myosin Activator, CK-1827452, on Cardiac Function, Hemodynamics, and Myocardial Oxygen Consumption in... by Parker, J.D, Michaels, A.D, Kass, D.A, Wolff, A.A, Felker, G.M, Malik, F.I

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    In Hospital Early (Within 5 Days) Worsening HF Predicts Adverse Outcome in Patients Admitted for AHF – Results from the Pre-RELAX-AHF Study

    In Hospital Early (Within 5 Days) Worsening HF Predicts Adverse Outcome in Patients Admitted for AHF – Results from the Pre-RELAX-AHF Study by Weatherley, B. Davison, Cotter, G, Felker, G.M, Teerlink, J.R, Filippatos, G, Greenberg, B, Voors, A, Metra, M, Teichman, S.L, Unemori, E

    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Effect of Omecamtiv Mecarbil in Patients with Ischemic and Non-Ischemic Heart Failure with Reduced Ejection Fraction: Results From COSMIC-HF

    Effect of Omecamtiv Mecarbil in Patients with Ischemic and Non-Ischemic Heart Failure with Reduced Ejection Fraction: Results From COSMIC-HF by Teerlink, John R., Felker, G.M. Ichael, McMurray, John J.V., Solomon, Scott D., Kurtz, Christopher E., Monslavo, Maria Laura, Johnston, James, Malik, Fady I., Honarpour, Narimon

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  6. 6
    020 - Effect of Omecamtiv Mecarbil in Patients with Ischemic and Non-Ischemic Heart Failure with Reduced Ejection Fraction: Results From COSMIC-HF

    020 - Effect of Omecamtiv Mecarbil in Patients with Ischemic and Non-Ischemic Heart Failure with Reduced Ejection Fraction: Results From COSMIC-HF by Teerlink, John R., Felker, G.M. Ichael, McMurray, John J.V., Solomon, Scott D., Kurtz, Christopher E., Monslavo, Maria Laura, Johnston, James, Malik, Fady I., Honarpour, Narimon

    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    Marks for SCALPEL ® tool optics optimization

    Marks for SCALPEL ® tool optics optimization by Farrow, R.C., Gallatin, G.M., Waskiewicz, W.K., Liddle, J.A., Kizilyalli, I., Kornblit, A., Biddick, C., Blakey, M., Klemens, F., Felker, J., Kraus, J., Mkrtchyan, M., Orphanos, P.A., Layadi, N., Merchant, S.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: